Sort
48,018 grants matching “immunotherapy”
Neonatal Porcine Islet Xenografts for the Treatment of Type 1 Diabetes
$943,871Allan D. Kirk · Duke University · U01 · FY2017 · AI
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
$943,403Bernhard Josef Hering · University Of Minnesota · U19 · FY2025 · AI
Overcoming resistance to anti-PD1 immunotherapy
$943,344Thomas F Gajewski · University Of Chicago · R35 · FY2021 · CA
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
$943,101Alexander H. Stegh · Washington University · R01 · FY2025 · CA
Development of Novel Therapies for Acute Lymphoblastic Leukemia
$943,000Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Broad spectrum therapeutics targeting resolvase enzymes
$942,460Frederic D Bushman · University Of Pennsylvania · U01 · FY2010 · AI
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$942,132Pablo Tamayo · University Of California, San Diego · U01 · FY2021 · CA
INVESTIGATING THE ROLE OF A NOVEL INHIBITORY RECEPTOR COMPLEX IN DRIVING T CELL DYSFUNCTION AND THERAPEUTIC RESISTANCE TOWARD IMMUNOTHERAPIES IN LUNG CANCER.
$942,000The Cleveland Clinic Foundation · · FY2022 · Defense Health Agency
Mechanism and therapeutic implication of RNA-modification-mediated codon-biased translation in acute myeloid leukemia
$941,798Jianjun Chen · Beckman Research Institute/City Of Hope · U01 · FY2025 · CA
PEDIATRIC AIDS CLINICAL TRIALS GROUP
$941,493Columbia University Health Sciences · U01 · FY2000 · AI
Immunoprevention and immunosurveillance of human non-viral cancers
$941,449Olivera J Finn · University Of Pittsburgh At Pittsburgh · R35 · FY2016 · CA
Overcoming resistance to anti-PD1 immunotherapy
$941,158Thomas F Gajewski · University Of Chicago · R35 · FY2017 · CA
Evaluation of the Immunogenicity and Efficacy of a MVA-HIV Prime, gp145 HIV protein/ALFA-adjuvanted Boost Vaccine Regimen with SHIV-CH505 Challenge in Male Rhesus Macaques
$941,082Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
A Comprehensive 5K Plus Glycan Microarray
$940,980Jian Zhang · Z Biotech, Llc · R44 · FY2021 · GM
Analysis and Modulation of Virus-Host Interaction in Infections of the Liver
$940,899Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Clinical Support
$940,088James J Vredenburgh · Duke University · P01 · FY2015 · CA
CCR FACS Core Laboratory
$939,713Karen Wolcott · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
GMP MANUFACTURE OF CLINICAL GRADE THERAPEUTIC VACCINE FOR THE TREATMENT OF PATIENTS WITH CHRONIC HBV
$939,695Valerian Nakaar · Carogen Corporation · R44 · FY2021 · DK
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
$939,552Frederick Oliver Cope · Navidea Biopharmaceuticals, Inc. · R44 · FY2017 · CA
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$939,361Xihong Lin · Harvard School Of Public Health · R35 · FY2022 · CA
Clinical-Virology Core
$939,238Kari C. Nadeau · Stanford University · U54 · FY2020 · CA
Deciphering the crosstalk between bacteria and their mammalian hosts
$939,000Aaron Thomas Whiteley · University Of Colorado · DP2 · FY2025 · AT
STAMPOUT: A Phase 2a Study of Antibody for Methamphetamine Outpatient Therapy
$938,893Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2019 · DA
High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures
$938,647Benjamin Biron Yellen · Celldom, Inc. · R44 · FY2024 · CA
Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer
$938,597Christopher D Pack · Metaclipse Therapeutics Corporation · R44 · FY2022 · CA